Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, January 19, 2010

abstract: Safety and efficacy results of the advanced renal cell carcinoma Sorafenib expanded access program in North America

Note: while this is not specific to ovarian cancer knowing the side effects which patients experienced may be helpful

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.